Improvement of platelets after SVR among patients with chronic HCV infection and advanced hepatic fibrosis-Reference-Cited by-同舟云学术

Improvement of platelets after SVR among patients with chronic HCV infection and advanced hepatic fibrosis

Published:2016-05-30 Issue:6 Volume:31 Page:1168-1176
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:Journal of Gastroenterology and Hepatology

Author:

van der Meer Adriaan J¹,Maan Raoel¹,Veldt Bart J¹,Feld Jordan J²,Wedemeyer Heiner³,Dufour Jean-François⁴,Lammert Frank⁵,Duarte-Rojo Andres⁶,Manns Michael P³,Zeuzem Stefan⁷,Hofmann W Peter⁷,de Knegt Robert J¹,Hansen Bettina E¹,Janssen Harry LA¹²

Affiliation:

1. Department of Gastroenterology and Hepatology; Erasmus MC University Medical Center Rotterdam; Rotterdam The Netherlands

2. The Toronto Centre for Liver Disease; University Health Network; Toronto Ontario Canada

3. Department of Gastroenterology, Hepatology, and Endocrinology; Medical School Hannover; Hannover Germany

4. Hepatology, Department of Clinical research; University of Bern; Bern Switzerland

5. Department of Medicine II; Saarland University Medical Center; Homburg Germany

6. Division of Gastroenterology and Hepatology; University of Arkansas for Medical Sciences; Arkansas USA

7. Medizinische Klinik 1; Klinikum der Johann Wolfgang Goethe-Universität; Frankfurt am Main Germany

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jgh.13252/fullpdf

Reference52 articles.

1. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients;Fattovich;Gastroenterology,1997

2. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups;Poynard;Lancet,1997

3. Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression;Davis;Gastroenterology,2010

4. Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection;Afdhal;N. Engl. J. Med.,2014

5. Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection;Afdhal;N. Engl. J. Med.,2014

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Kupffer cells and other immune cells;Sinusoidal Cells in Liver Diseases;2024

2. Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals;BMC Gastroenterology;2023-05-25

3. Indicators of the hemostasis system and markers of endothelial damage in patients with steatosis and liver fibrosis;Meditsinskiy sovet = Medical Council;2023-05-25

4. Spleen size change after hepatitis C treatment: a simple parameter to predict clinical outcomes;Journal of Investigative Medicine;2023-05-05

5. Serum retinol-binding protein 4 as a predictor of fibrosis regression and response to direct-acting antiviral drugs in chronic hepatitis C virus patients;Egyptian Liver Journal;2023-03-30